, glutamic acid-and leucine-rich protein 1 (PELP1) is an oestrogen receptor (ER) coregulator protein identified by our collaborative group. Work from our laboratory and others has shown that PELP1 is a scaffold protein that interacts with ERs and kinase signalling factors, as well as proteins involved in chromatin remodelling and DNA repair.
| INTRODUCTION
The steroid hormone, 17β-oestradiol (E 2 ) is primarily produced in the ovaries in females and circulates in the bloodstream to regulate various target tissues, including the brain. 1 As a lipophilic steroid hormone, E 2 can enter cells and bind to oestrogen receptors (ER) in extranuclear and nuclear compartments to exert its actions. Although much is known about how E 2 exerts oestrogen receptor-mediated actions to regulate gene transcription, comparatively less is known about how E 2 exerts rapid extranuclear signalling in cells.
| Evidence of E 2 neuroprotective effects
A large number of clinical and basic science studies have shown sex differences and implicated a neuroprotective role for E 2 in neurodegenerative disorders such as Alzheimer's disease, [2] [3] [4] [5] Parkinson's disease 1, 6 and stroke. 7-13 E 2 neuroprotection has been suggested to involve mediation by both the classical nuclear and extranuclear oestrogen receptors, ESR1 (also known as ERα) and ESR2 (also known as ERβ). [14] [15] [16] [17] [18] [19] [20] [21] [22] In addition, emerging evidence suggests that G-protein coupled oestrogen receptor-1 (GPER1, also known as GPR30) may also participate as an extranuclear receptor for oestrogen to mediate the neuroprotective actions of E 2 .
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| Multiple mechanisms of E 2 neuroprotection
The mechanisms underlying E 2 neuroprotection have been studied extensively in recent years. The findings from these studies suggest that E 2 neuroprotection is mediated via regulatory effects upon multiple pathways and processes in cells, 26 including: (i) genomic nuclear-receptor mediated signalling that regulates transcription of pro-survival, anti-apoptotic and anti-inflammatory factors; (ii) rapid extranuclear receptor-mediated signalling that enhances pro-survival kinase signalling pathways that can cross-talk to the nucleus and control transcription of protective and anti-inflammatory factors;
(iii) anti-oxidative stress effects that are mediated by suppression of free radical generation through regulatory effects on membrane NADPH oxidase-and mitochondrial-generating reactive oxygen species systems; 17, [26] [27] [28] and (iv) enhancement/preservation of mitochondrial bioenergetics, 27 which could help cells survive stressful situations and be more resistant to damage.
It has been recently reported by our laboratory that the oestrogen receptor co-regulator, proline-, glutamic acid-and leucine-rich protein 1 (PELP1) has a critical role in mediating E 2 signalling and actions in the brain. This review discusses the latest findings in the field that shed new light on the understanding of PELP1 structure, function and signalling in the brain, particularly as it relates to E 2 signalling, as well as its neuroprotective, anti-inflammatory and cognitive-enhancing actions.
| PELP1: A NOVEL ER COREGULATOR
Investigations into the signalling mechanisms underlying the actions of E 2 have revealed that E 2 -induced ER transcriptional activity can be influenced by "coregulator" proteins, which function as "coactivators" or "corepressors". 29 Functionally, coregulator proteins act as a facilitator, modulator or bridge to form large protein complexes and regulate target gene activity on chromatin. The ER-co-regulator protein association thus leads to formation of an "ER signalosome", which facilitates both ER-nuclear and -extranuclear receptor-mediated action. To date, the majority of work on ER co-regulators has been performed in the cancer field, with little known about their function in the brain. However, recent work by our group led to the cloning and characterisation of a novel ER co-regulator that is highly expressed in the brain, called PELP1, [30] [31] [32] and which appears to play a key role in E 2 signalling in the brain.
| PELP1 structure
Human PELP1 is localised on the chromosomal region 17p13.2 and encodes a 1130 amino acid protein. 33 The PELP1 gene is highly conserved across species. In humans, both a long (3.8 kb) and a short (3.4 kb) transcript have been identified. The long transcript is an immature transcript and has an extra 435-bp intron. The short isoform is the mature transcript and is widely expressed in tissues throughout the body. PELP1 lacks known enzymatic activity and its action in cells appears to be a result of the many protein-protein interaction motifs in its structure, which allow it to function as a scaffolding protein coupling various proteins to transcription factors, nuclear receptors, kinases and other proteins 33 ( Figure 1 ).
For example, PELP1 contains 10 NR-interacting boxes (LXXLL motifs) that allow its interactions with NRs, including oestrogen receptors. 30 In addition, the C-terminus of PELP1 contains 70 acidic amino acids that function as a histone-binding region ( Figure 1 ). 
| PELP1 expression
PELP1 expression is highest in the brain, testes, ovaries and uterus. 30, 31, 37, 38 In the brain, PELP1 has been reported to be expressed in many regions, including the hippocampus, hypothalamus, cerebellum, cerebral cortex, amygdala and bed nucleus of the stria terminalis. 31, 32, 38, 39 In the mammary gland, PELP1 expression is developmentally regulated. 30 Further work by our group has shown that PELP1 is an oestrogen receptor (ESR) target gene, with two oestrogen-response element half sites in the promoter, and is upregulated by both ESR1 and ESR2. 40 Intriguingly, PELP1 can exhibit both cytoplasmic and nuclear localisation, indicating that it could mediate both extranuclear and nuclear actions of E 2 . 30 In the nucleus, PELP1 has been demonstrated to localise in the chromatin, nucleoplasm and nuclear matrix. 
| PELP1 regulation
Post-translational phosphorylation is the main mechanism of regulation of PELP1 activity. Phosphorylation can control localisation of PELP1, its interaction with adaptor proteins, and its stability. 33, 41, 42 PELP1 is phosphorylated by both hormonal and growth factor signals.
Phosphorylation of PELP1 can be promoted by growth factors via protein kinase A (PKA) at Ser
350
, Ser 415 and Ser 613 ( Figure 1 ). 43 Recent work by our group demonstrated that glycogen synthase kinase 3 β (GSK3β) phosphorylates PELP1 at Thr 745 and Ser 1059 in the brain and thereby controls the stability of PELP1. 42 Phosphorylation of PELP1
at Ser 477 and Ser 991 by cyclin dependent kinases (CDKs) has been reported to occur in a cell cycle-dependent manner. 44 Finally, it has been reported that DNA damage induced kinases (ATM, ATR) can also phosphorylate PELP1 on Ser
1033
. 45 Functionally, phosphorylation of PELP1 can lead to coupling of physiological signals to nuclear receptors and transcriptional factors. predictor of shorter breast cancer-specific survival and diseasefree interval. 66 Another example of this is the correlation between cytoplasmic levels of PELP1 and poor response of patients to tamoxifen. 67 For further discussion of the role of PELP1 in cancer progression, treatment and prognosis, previous reviews on the subject are available. 
| PELP1 interactome

| PELP1: A KEY MEDIATOR OF E 2 SIGNALLING AND ACTIONS IN THE BRAIN
As noted previously, PELP1 is widely expressed in many regions of the brain of both rodents and monkeys, including key forebrain regions such as the hippocampus, hypothalamus and cerebral cortex.
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Subcellular localisation studies revealed that PELP1 is highly localised in the cell nucleus of neurones, with a smaller amount located in the cytoplasm. 32 PELP1 has a nuclear localisation signal that targets it to the nucleus. 33 In addition, hepatocyte growth factor-regulated tyrosine kinase substrate interacts with PELP1 and can sequester it in the cytoplasm. 6 Electron microscopy studies further showed that PELP1
is localised in the cell membrane, dendritic shafts, and pre-and postsynaptic terminals of neurones. 31 In addition to localisation in neurones, PELP1 is also expressed in astrocytes. 38 Furthermore, PELP1
expression is reportedly markedly decreased in the brain of aged mice. 69 Co-localisation studies have further revealed that PELP1 is colocalised in ESR1-positive cells in various brain regions. 31 Currently, it is not known whether PELP1 similarly co-localises with ESR2 or GPER1 in the brain.
| Establishment of PELP1 forebrain-specific knockout mouse model
To better clarify the role of PELP1 in E 2 genomic and nongenomic signalling and actions in the brain, our group recently created a PELP1
forebrain-specific knockout mouse model (PELP1 FBKO) using Cre/ loxP technology. 
| PELP1 mediates rapid extranuclear E 2 signalling
To study the role of PELP1 in E 2 effects upon rapid extranuclear signalling, gene expression, neuroprotection and cognition, we utilised a global cerebral ischaemia (GCI) mouse model of brain ischemia, which causes extensive damage to the highly vulnerable hippocampus CA1 region. Using the GCI model, our studies revealed that E 2 -mediated extranuclear signalling in the hippocampus to rapidly activate prosurvival ERK and Akt signalling was lost in PELP1 FBKO mice compared to FLOX control mice. 42 In addition, the ability of E 2 to suppress activation of the pro-apoptotic factor, JNK was also lost in the PELP1 FBKO mouse. These results were also confirmed using an acute PELP1
antisense knockdown approach after GCI in a rat model. 42 Based on these results, it was suggested that E 2 rapid signalling in the brain is likely a result of the ability of PELP1 to form a scaffolding complex between ER and kinase signalling pathway proteins. Indeed, further studies showed that E 2 enhanced PELP1 interaction with ESR1, Src and p85 subunit of PI3 kinase in the hippocampus rapidly after GCI.
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As a whole, these findings suggest that PELP1 is essential for mediating E 2 rapid, extranuclear activation of prosurvival ERK and Akt in the brain after an ischaemic injury. 42 Furthermore, these results in the brain agree well with previous work demonstrating that PELP1
mediates E 2 -induced activation of mitogen-activated protein kinase (MAPK) and PI3K-Akt signalling in cancer cells. 
| PELP1 and GSK3β-Wnt-β-catenin signalling
In addition to regulating E 2 activation of prosurvival kinase signalling pathways, PELP1 also mediates E 2 inhibition of neurodegenerative kinase signalling pathways in the brain such as GSK3β. GSK3β is a key mediator of cell death in several neurodegenerative conditions, including cerebral ischaemia 71, 72 and Alzheimer's disease. 73 Inhibition of GSK3β has been shown to improve functional recovery after cerebral ischaemia. Several kinases, such as Akt, p70S6K, p90RSK, PKA and MAPK, can phosphorylate GSK3β leading to its inactivation. 74 Furthermore, E 2 has been shown to increase phosphorylation of GSK3β leading to its inhibition. 75 GSK3β is also a key player in the Wnt signalling pathway where it can negatively regulate pro-survival signalling by phosphorylation of β-catenin, resulting in its degradation.
Studies from our laboratory have also shown that E 2 can up-regulate β-catenin after GCI. 3 Based on the strong link between E 2 and GSK3β/ Wnt-catenin signalling, we therefore used the PELP1 FBKO mice to examine the role of PELP1 in mediating E 2 regulation of GSK-3β
and β-catenin in the hippocampus after GCI. 42 The results revealed that the ability of E 2 to inactivate GSK3β and increase pro-survival β-catenin levels in the hippocampus after GCI was also lost in the PELP1 FBKO mice. 42 To identify PELP1 interacting proteins in the brain, we utilised PELP1 pulldown and mass spectrometry. The proteomic interactor screening identified many PELP1-interactng proteins in the brain, including, most interestingly, GSK3β. 42 Further studies determined that GSK3β binds to the 400-600 amino acids region of PELP1, with a minor interaction also noted at the 1-400 amino acids region of PELP1. 42 Mapping studies revealed that GSK3β phosphorylates PELP1 at Thr 745 and Ser 1059 (Figure 1 ), which leads to its degradation. 42 These results revealed that PELP1 is a novel substrate of GSK3β and indicated that an autocrine loop, involving E 2 -ER-GSK3β
signalling may be involved in modulating the levels of PELP1 at the site of neuronal damage.
| PELP1 mediates E 2 neuroprotection and cognition after ischaemic injury
It is known that E 2 can decrease neuronal damage and increase the number of surviving neurones after cerebral ischaemia, as well as preserve cognitive function. 1, 3, 8 Therefore, we utilised the PELP1 FBKO mice to determine the importance of PELP1 in mediating these key functional outcomes after cerebral ischaemia. The results
revealed that E 2 treatment after cerebral ischaemia improved neuronal survival and cognitive outcome in terms of spatial learning and memory. This ability of E 2 to enhance neuronal survival and preserve cognitive function after GCI was lost in the PELP1 FBKO mice. 42 The role of PELP1 in mediating the neuroprotective and cognitive effects of E 2 was also confirmed using an acute PELP1 antisense knockdown approach after GCI in a rat model. Taken as a whole, these results suggest that PELP1 mediates E 2 rapid prosurvival signalling in the brain, as well as its neuroprotective and cognitive preserving actions after cerebral ischaemia. The majority of genes that were altered in PELP1 FBKO mice were involved in tissue development and function, cellular assembly and organisation, neurological diseases and inflammation. These altered genes in PELP1 FBKO mice were part of key cellular pathways including neuroinflammation/neuronal death, chemokine signalling, Wnt pathway, cellular movement, cell-to-cell interactions, death, apoptosis, survival and DNA repair. 42 The identification of the inflammatory pathway as a major PELP1-regulated pathway in the brain was interesting.
| PELP1 regulates unique gene networks in the brain
In follow-up studies, we confirmed that E 2 strongly suppresses activation of a major pro-inflammatory pathway in the brain: the NLRP3 inflammasome pathway. 76 Further work using PELP1 FBKO mice confirmed that PELP1 is essential for E 2 suppression of the NLRP3 inflammasome pathway, including downstream pro-inflammatory cytokine production. Taken together, these recent findings from our laboratory suggest an essential role for PELP1 in E 2 -mediated rapid extranuclear signalling, genomic signalling, neuroprotection, cognitive function and neuroinflammation in the ischaemic brain.
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| CONCLUSIONS
Although much of what we know about PELP1 has originated from studies in cancer cells, there is now growing evidence that PELP1 has a key role in mediating beneficial E 2 signalling and actions in the brain. A significant advance in clarifying the roles and functions of PELP1 in the brain came from the generation of a novel PELP1 FBKO animal model.
Use of the PELP1 FBKO mouse has revealed that PELP1 is critical for mediating E 2 regulation of rapid extranuclear prosurvival signalling in the brain, as well as E 2 -induced neuroprotection and cognitive function in the hippocampus after ischaemic injury. Because PELP1 lacks any known enzyme activity, its effects in the brain appear to be a result of its ability to interact with many different proteins in the cell and function as a scaffold protein. RNA-Seq analysis further revealed that PELP1 regulates many genes in the brain, including those involved in neurological diseases and inflammation, Wnt signalling and other key processes of the cell. Although much has been learned abour the role of PELP1 in the brain, considerable more remains to be determined.
For example, additional studies are needed to clarify whether PELP1 exerts important epigenetic functions in the brain because it binds to histones and interacts with many chromatin-remodelling enzymes.
Furthermore, the role of PELP1 in mediating other nuclear receptor functions in the brain, in addition to oestrogen receptors, also remains to be explored. Nevertheless, taken as a whole, the studies discussed in this review suggest an emerging important role of PELP1 in mediating E 2 signalling and actions in the brain.
